<?xml version="1.0" encoding="UTF-8"?>
<ref id="R56">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Ising</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Venegas</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Zhang</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Scheiblich</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Schmidt</surname>
   <given-names>SV</given-names>
  </name>, 
  <name>
   <surname>Vieira-Saecker</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Schwartz</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Albasset</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>McManus</surname>
   <given-names>RM</given-names>
  </name>, 
  <name>
   <surname>Tejera</surname>
   <given-names>D</given-names>
  </name>, 
  <etal/> (
  <year>2019</year>). 
  <article-title>NLRP3 inflammasome activation drives tau pathology</article-title>. 
  <source>Nature</source>
  <volume>575</volume>, 
  <fpage>669</fpage>â€“
  <lpage>673</lpage>.
  <pub-id pub-id-type="pmid">31748742</pub-id>
 </mixed-citation>
</ref>
